← Leaderboards
Daniel B Rifkin
New York University School Of Medicine
$20,829,657
Attributed
$20,829,657
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$32,916,188 · 15
By mechanism
P01$18,544,036 · 5
R01$10,992,424 · 5
T32$2,667,628 · 1
R21$677,100 · 2
R13$35,000 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Nada A. Abumrad$17,455,079
Others in their field
Top investigators on “Binding Proteins”
- Barton F Haynes · Duke University$99,233,321
- David Heimbrook · Leidos Biomedical Research, Inc.$96,490,307
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Michael P Snyder · Yale University$64,416,845
- Alice Telesnitsky · University Of Michigan At Ann Arbor$51,513,556
- Adam L Boxer · Mayo Clinic Rochester$51,057,712
Research focus
Binding ProteinsTransforming Growth FactorsCellsPhenotypeComplexInsightSignal TransductionIn VitroMutantReceptorMutationTissuesLaboratory MouseMonitorAffectGenesGeneticCytokineResearch StudyProteinsBasePathologyTransforming Growth Factor BetaProduction
Grant awards (79)
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm$2,393,711
P01 · FY2022 · HL · contact PI
Altered Mechanotransduction$437,901
P01 · FY2022 · HL · contact PI
Core A-Administrative Core$191,559
P01 · FY2022 · HL · contact PI
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm$2,397,289
P01 · FY2021 · HL · contact PI
Altered Mechanotransduction$438,109
P01 · FY2021 · HL · contact PI
Core A-Administrative Core$191,763
P01 · FY2021 · HL · contact PI
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm$2,400,712
P01 · FY2020 · HL · contact PI
Altered Mechanotransduction$438,306
P01 · FY2020 · HL · contact PI
Core A-Administrative Core$191,960
P01 · FY2020 · HL · contact PI
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm$2,403,188
P01 · FY2019 · HL · contact PI
Altered Mechanotransduction$438,449
P01 · FY2019 · HL · contact PI
Core A-Administrative Core$192,102
P01 · FY2019 · HL · contact PI
2019 Elastin, Elastic Fibers and Microfibrils Gordon Research Conference and Seminar$15,000
R13 · FY2019 · AR · contact PI
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm$2,491,631
P01 · FY2018 · HL · contact PI
Altered Mechanotransduction$450,949
P01 · FY2018 · HL · contact PI
Core A-Administrative Core$204,603
P01 · FY2018 · HL · contact PI
2017 Elastin, Elastic Fibers & Microfibrils Gordon Research Conference & Gordon Research Seminar$20,000
R13 · FY2017 · AR · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$339,621
R01 · FY2016 · CA · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$340,896
R01 · FY2015 · CA · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$344,549
R01 · FY2014 · CA · contact PI
Nodal Points in Marfan Syndrome Progression$368,001
P01 · FY2013 · AR · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$321,669
R01 · FY2013 · CA · contact PI
Graduate Program in Cellular and Molecular Biology$176,748
T32 · FY2013 · GM · contact PI
Graduate Program in Cellular and Molecular Biology.$96,050
T32 · FY2013 · GM · contact PI
Mechanisms for Latent TGF-beta1 Activation In Vivo$435,146
R01 · FY2012 · GM · contact PI
Nodal Points in Marfan Syndrome Progression$389,746
P01 · FY2012 · AR · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$343,533
R01 · FY2012 · CA · contact PI
Graduate Program in Cellular and Molecular Biology$178,618
T32 · FY2012 · GM · contact PI
Mechanisms for Latent TGF-beta1 Activation In Vivo$435,146
R01 · FY2011 · GM · contact PI
Nodal Points in Marfan Syndrome Progression$421,962
P01 · FY2011 · AR · contact PI
Regulation of TGF-Beta Activity in the Lung by LTBP-4$370,701
R01 · FY2011 · CA · contact PI
Graduate Program in Cellular and Molecular Biology$176,752
T32 · FY2011 · GM · contact PI
Mechanisms for Latent TGF-beta1 Activation In Vivo$441,137
R01 · FY2010 · GM · contact PI
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung$389,663
R01 · FY2010 · CA · contact PI
Nodal Points in Marfan Syndrome Progression$354,692
P01 · FY2010 · AR · contact PI
TGF-Beta and Inflammation in Gastric Cancer$186,450
R21 · FY2010 · CA · contact PI
Graduate Program in Cellular and Molecular Biology$174,938
T32 · FY2010 · GM · contact PI
Mechanisms for Latent TGF-beta1 Activation In Vivo$434,228
R01 · FY2009 · GM · contact PI
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung$383,854
R01 · FY2009 · CA · contact PI
Nodal Points in Marfan Syndrome Progression$365,424
P01 · FY2009 · AR · contact PI
TGF-Beta and Inflammation in Gastric Cancer$186,450
R21 · FY2009 · CA · contact PI
Graduate Program in Cellular and Molecular Biology$174,056
T32 · FY2009 · GM · contact PI
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung$374,411
R01 · FY2008 · CA · contact PI
Cell Signaling in Marfan Syndrome$310,683
P01 · FY2008 · AR · contact PI
Graduate Program in Cellular and Molecular Biology$140,917
T32 · FY2008 · GM · contact PI
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung$371,363
R01 · FY2007 · CA · contact PI
Cell Signaling in Marfan Syndrome$267,486
P01 · FY2007 · AR · contact PI
Graduate Program in Cellular and Molecular Biology$166,103
T32 · FY2007 · GM · contact PI
Isoform Specificities of the Latent TGF-beta Binding Proteins in Lung$371,315
R01 · FY2006 · CA · contact PI
PROJECT 3: Cell Signaling in Marfan Syndrome (Daniel Rifkin, Ph.D.)$274,885
P01 · FY2006 · AR · contact PI
Graduate Program in Cellular and Molecular Biology$166,103
T32 · FY2006 · GM · contact PI
PROJECT 3: Cell Signaling in Marfan Syndrome (Daniel Rifkin, Ph.D.)$267,840
P01 · FY2005 · AR
A Genetic Screen for Latent TGF-beta Activators$152,100
R21 · FY2005 · CA
Graduate Program in Cellular and Molecular Biology$114,527
T32 · FY2005 · GM
DEVELOPMENTAL ACTIVITIES OF LATENT TGF-B BINDING PROTEIN$371,250
R01 · FY2004 · CA
TGF-BETA PRESENTATION IN BONE BIOLOGY$368,545
R01 · FY2004 · DE
PROJECT 3: Cell Signaling in Marfan Syndrome (Daniel Rifkin, Ph.D.)$261,085
P01 · FY2004 · AR
Graduate Program in Cellular and Molecular Biology$166,103
T32 · FY2004 · GM
A Genetic Screen for Latent TGF-beta Activators$152,100
R21 · FY2004 · CA
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$76,353
R01 · FY2004 · CA
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$377,203
R01 · FY2003 · CA
DEVELOPMENTAL ACTIVITIES OF LATENT TGF-B BINDING PROTEIN$371,250
R01 · FY2003 · CA
TGF-BETA PRESENTATION IN BONE BIOLOGY$355,145
R01 · FY2003 · DE
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY$251,331
T32 · FY2003 · GM
DEVELOPMENTAL ACTIVITIES OF LATENT TGF-B BINDING PROTEIN$371,250
R01 · FY2002 · CA
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$369,374
R01 · FY2002 · CA
TGF-BETA PRESENTATION IN BONE BIOLOGY$341,027
R01 · FY2002 · DE
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY$239,589
T32 · FY2002 · GM
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$75,210
R01 · FY2002 · CA
DEVELOPMENTAL ACTIVITIES OF LATENT TGF-B BINDING PROTEIN$365,400
R01 · FY2001 · CA
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$360,177
R01 · FY2001 · CA
TGF-BETA PRESENTATION IN BONE BIOLOGY$297,196
R01 · FY2001 · DE
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY$227,562
T32 · FY2001 · GM
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$73,501
R01 · FY2001 · CA
TGF-BETA PRESENTATION IN BONE BIOLOGY$10,431
R01 · FY2001 · DE
MECHANISM OF ACTIVATION OF LATENT TGF BETA BY VASCULAR E$394,335
R01 · FY2000 · CA
DEVELOPMENTAL ACTIVITIES OF LATENT TGF-B BINDING PROTEIN$364,230
R01 · FY2000 · CA
BIOCHEMICAL AND GENETIC ANALYSIS OF LTBP-1$353,315
R01 · FY2000 · CA
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY$218,231
T32 · FY2000 · GM